Note: Ingredients listed on restricted chemical lists
EC/CAS
202-496-6/96-29-7
Name of the chemical
2-Butanonoxim (2020/1182)
Concentration
>=90-<=100
General Information
Version
1.3
Revision date
2025-08-22
Product name
2-Butanone Oxime
CAS No.
96-29-7
1.2.1 Relevant identified uses
Use as laboratory reagent
Emergency telephone
+44 844 892 0111
Icons in SDS
Company Information
company name
TCI EUROPE N.V
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H301, H312, H315, H317, H318, H336, H350, H370, H373, H412
Hazard statements
Code
Statements
H301
Toxic if swallowed
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
Danger
Hazard statements
H301 Toxic if swallowed. H312 Harmful in contact with skin. H315 Causes skin irritation. H317 May cause an allergic skin reaction. H318 Causes serious eye damage. H336 May cause drowsiness or dizziness. H350 May cause cancer. H370 Causes damage to organs (Upper respiratory tract). H373 May cause damage to organs (hematopoietic system) through prolonged or repeated exposure. H412 Harmful to aquatic life with long lasting effects.
Prevention
P201 Obtain special instructions before use. P260 Do not breathe mist or vapours. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection/ hearing protection.
Response
P301 + P310 + P330 IF SWALLOWED: Immediately call a POISON CENTER/ doctor. Rinse mouth. P305 + P351 + P338 + P310 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER/ doctor. P308 + P311 IF exposed or concerned: Call a POISON CENTER/ doctor.
Additional information
Restricted to professional users
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupt- ing properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commis- sion Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine dis- rupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Com- mission Regulation (EU) 2018/605 at levels of 0.1% or higher
2.1 Classification of the substance or mixture
Classification (REGULATION (EC) No 1272/2008) Acute toxicity, Category 3 H301: Toxic if swallowed. Acute toxicity, Category 4 H312: Harmful in contact with skin. Skin irritation, Category 2 H315: Causes skin irritation. Serious eye damage, Category 1 H318: Causes serious eye damage. Skin sensitisation, Category 1 H317: May cause an allergic skin reaction. Carcinogenicity, Category 1B H350: May cause cancer. Specific target organ toxicity - single expo- H370: Causes damage to organs. sure, Category 1, Upper respiratory tract Specific target organ toxicity - single expo- H336: May cause drowsiness or dizziness. sure, Category 3, Central nervous system Specific target organ toxicity - repeated expo- H373: May cause damage to organs through prolonged sure, Category 2, hematopoietic system or repeated exposure. Long-term (chronic) aquatic hazard, Category H412: Harmful to aquatic life with long lasting effects. 3